Racemomycin B
Racemomycin B (229-B; Streptothricin D), the main component from Streptomyces lavendulae OP-2, is a streptothricin antibiotic containing three β-lysine groups. RM-B exhibits antimicrobial activity against plant pathogenic microorganisms and effectively inhibits the growth of Brassica rapa L. roots at 50 ppm. RM-B showed a minimum inhibitory concentration (MIC) of 0.4 μg/ml against Pseudomonas syringae pv. tabaci IFO-3508 and a MIC range of 0.1-2.0 μg/ml against six strains of Fusarium oxysporum, showing stronger antimicrobial activity than RM-A and RM-C. The biological activity of racemomycin compounds increases with the increase in the number of β-lysine groups.
Product Specifications
CAS Number
[3776-37-2]
Product Name Alternative
229-B; Streptothricin D
UNSPSC
12352005
Target
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/racemomycin-b.html
Smiles
O=C(NC[C@H]1O)[C@]2([H])[C@]1([H])NC(N[C@H]3[C@@H]([C@@H]([C@@H](OC(N)=O)[C@@H](CO)O3)O)NC(C[C@@H](N)CCCNC(C[C@@H](N)CCCNC(C[C@@H](N)CCCN)=O)=O)=O)=N2
Molecular Formula
C31H58N12O10
Molecular Weight
758.87
References & Citations
[1]Biological Activities of Racemomycin-B, B-Lysine Rich Streptothricin Antibiotic, the Main Component
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Gadd45a shRNA (UAS) - Lentiviral mouse Gadd45a shRNA (UAS) (25)
DR4, Recombinant, Human (TRAIL R1, TRAIL Receptor1, Death Receptor4)
DR4, Recombinant, Human (TRAIL R1, TRAIL Receptor1, Death Receptor4)